Is the Ochratoxin A a mutagenic mycotoxine?;¿Es la Ocratoxina A una micotoxina mutagénica?

Revista de Toxicologia

Volumn 21, Issue 1, 2004, Pages 1-10

  Arbillaga, L ^a   Ezpeleta, O ^a   Lopez De Cerain A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Adducts; Genotoxicity; Mutagenicity; Mycotoxins; Ochratoxin A

Indexed keywords

4 HYDROXYOCHRATOXIN A; CYTOCHROME P450; MUTAGENIC AGENT; OCHRATOXIN; REACTIVE OXYGEN METABOLITE; SINGLE STRANDED DNA; TOXIN; UNCLASSIFIED DRUG;

ASPERGILLUS; CARCINOGENICITY; CELL CYCLE S PHASE; CHROMOSOME ABERRATION; CYTOTOXICITY; DNA BINDING; DNA STRAND BREAKAGE; DNA SYNTHESIS; GENOTOXICITY; HUMAN; IMMUNOTOXICITY; IN VIVO STUDY; LIPID PEROXIDATION; LIVER TOXICITY; MUTAGENICITY; NEPHROTOXICITY; NONHUMAN; PENICILLIUM; REVIEW; SISTER CHROMATID EXCHANGE; SYSTEMATIC REVIEW; TERATOGENICITY;

ASPERGILLUS; BACTERIA (MICROORGANISMS); PENICILLIUM;

EID: 2542574143     PISSN: 02127113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Van der Merwe KJ, Steyn PS, Fourie L, Scott B, Theron JJ (1965). Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus. Nature 4976: 1112-3.
2. Xiao H, Madhyastha S, Marquardt RR, Li S, Vodela JK, Frohlich AA, Kemppainen BW (1996). Toxicity of ochratoxin A, its opened lactone form and several of its analoges: structure-activity relationships. Toxicol Appl Pharmacol 137: 182-92.
3. Moss MO (1996). Mycotoxins. Mycol Res 100: 513-23.
4. European Commission (1995). Assessment of dietary intake of ochratoxin A by the population in EU member states. 3° informe SCOOP. (Working document in support of a SCF risk assessment of ochratoxin A). Coordinador: Dinamarca. Noviembre.
5. Legarda TM y Burdaspal PA (1998). Ocratoxina A en cervezas elaboradas en España y en otros países Europeos. Alimentaria, abril: 115-22.
6. Studer-Rohr I, Dietrich DR, Schlatter J, Schlater C (1995). The occurrence of ochratoxin A in coffee. Food Chem Toxicol 33: 341-55.
7. Zimmerli B y Dick R (1996). Ochratoxin A in table wine and grape- juice: occurrence and risk assessment. Food Addit Contam 13: 655-68.
8. Burdaspal PA y Legarda TM (1999) Ocratoxina A en vinos, mostos y zumos de uva elaborados en España y en otros países europeos. Alimentaria, enero-febrero: 107-13.
9. Krogh P (1987). Ochratoxicosis in food. En: Mycotoxins in food. Krogh P, editor. Food science and technology, series monographs. Academic Press.
10. Josefsson EBG y Möller TE (1980). Heat stability of ochratoxin A in pig products. J Sci Food Agr 31: 1313-5.
11. Jorgensen K (1998). Survey of pork, poultry, coffee, beer and pulses for ochratoxin A. Food Addit Contam 15: 550-4.
12. Jiménez AM, López de Cerain A, González-Peñas E, Bello J (2001). Determination of OTA in pig liver derived pâtés by high-performance liquid chromatography. Food Addit Contam 18: 559-63.
13. Kuiper-Goodman y Scott PM (1989). Risk assessment of the mycotoxin ochratoxin A. Review. Biomedical and Environmental sciences 2: 179-248.
14. Di Paolo N, Guarnieri A, Garosi G, Sacchi G, Mangiarotti AM, Di Paolo M (1994). Inhaled mycotoxins lead to acute renal failure. Nephrol Dial Transplant 9 Suppl 4: 116-20.
15. Kumagai S y Aibara K (1982). Intestinal absortion and secretion of ochratoxin A in the rat. Toxicol Appl Pharmacol 64: 94-102.
16. Chu FS (1971). Interaction of ochratoxin A with bovine serum albumin. Arch Biochem Biophys 147: 359-66.
17. Chu FS (1974). A comparative study of the interaction of ochratoxins with bovine serum albumin. Biochem Pharmacol 23: 1105-13.
18. Schlatter CH, Studer-Rohr J, Rásonyi TH (1996). Carcinogenicity and kinetic aspects of ochratoxin A. Food Addit Contam 13: 43-4.
19. Hamilton PB, Huff WE, Harris JR, Wyatt RD (1982). Natural occurrences of ochratoxicosis in poultry. Poult Sci 61: 2172-4
20. Bozic Z, Duancic V, Belicza M, Kraus O, Skljarov I (1995). Balkan endemic nephropathy: still a mysterious disease. Eur J Epidemiol 11: 235-8.
21. Plestina R (1996). Nephrotoxicity of ochratoxin A. Food Addit Contam 13 Suppl: 49-50.
22. IARC (1993). Ochratoxin A. En: Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC Monographs on the evaluation of carcinogenic risks to humans. Lyon. Vol. 56: 489-521.
23. Gekle M, Gabner B, Freudinger R, Mildenberger S, Silbernagl S, Pfaller W Schramek H (1998). Characterization of an ochratoxin A dedifferentiated and cloned renal epithelial cell line. Toxicol Appl Pharmacol 152: 282-91.
24. Schramek H, Wilflingseder D, Pollack V, Freudinger R, Mildenberger S, Gekle M (1997). Ochratoxin A-induced stimulation of extracellular signal-regulated kinases 1/2 is associated with Madin-Darby canine kidney-C7 cell dedifferentiation. J Pharmacol Exp Ther 283: 1460-7.
25. Benesic A, Mildenberger S, Gekle M (2000). Nephritogenic ochratoxin A interferes with hormonal signalling in immortalized human kidney epithelial cells. Pflüg Arch 439: 278-87.
26. Gekle M, Schwerdt G, Freudinger R, Mildenberger S, Wilflingseder D, Pollack V, Dander M y Schramek H (2000). Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations. J Pharmacol Exp Ther 293: 837-44.
27. Horvath A, Upham BL, Ganey V, Trosko JE (2002). Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line. Toxicon 40: 273-82.
28. Thuvander A, Paulsen JE, Axberg K, Johansson N, Vidnes A, Enghardt-Barbieri H, Trygg K, Lund-Larsen S, Jahrl S, Widenfalk A, Bosnes V, Alexander J, Hult K y Olsen M (2001). Levels of ochratoxin A in blood from Norwegian and Swedish blood donors and their possible correlation with food consumption. Food Chem Toxicol 39: 1145-51.
29. Frohlich AA, Marquardt RR, Ominski KH (1991). Ochratoxin A as a contaminant in the human food chain: a Canadian perspective. En: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H. Ed. Mycotoxins, endemic nephropathy and urinary tract tumours. IARC Scientific Publications, Lyon 115: pp. 139-43.
30. Tápai K, Téren J, Mesterházy A (1997). Ochratoxin in the sera of blood donors and ill persons. Proceedings of the fifth European Fusarium seminar, Szeged Hungria. pp. 307-8.
31. Wafa EW, Yahya RS, Sobh MA, Eraky I, El Baz M, El Gayar HA, Betbeder AM, Creppy EE (1998). Human ochratoxicosis and nephropathy in Egypt: a perliminary study. Human Exp Toxicol 17: 124-9.
32. Gilbert J, Brereton P, MacDonalds S (2001). Assessment of dietary exposure to ochratoxin A in UK using a duplicate diet approach and analysis of urine and plasma samples. Food Addit Contam 18(12): 1088-93.
33. Grosso F, Saïd S, Mabrouk I, Fremy JM, Castegnaro M, Jemmali M, Dragacci S (2003). New data on the occurrence of ochratoxin A in human sera from patients affected or not by renal diseases in Tunisia. Food Chem Toxicol 41: 1133-40.
34. Jiménez AM, López de Cerain A, González-Peñas E, Bello J, Betbeder AM, Creppy EE (1998). Exposure to a ochratoxin A in Europe: comparison with a region of northen Spain. J Toxicol Toxin Rev 17: 479-91.
35. Malir F, Roubal T, Brndiar M, Osterreicher J, Severa J, Knizek J, Kacerovsky J, Tmejova M, Betbeder AM, Braudimont I, Creppy EE (2001). Ochratoxin A in the Czech republic. J Toxicol Toxin Rev 20 (3-4): 261-74.
36. Pérez de Obanos A, López de Cerain A, Jiménez AM, González-Peñas E, Bello J (2001). Ocratoxina A en plasma humano: nuevos datos de exposición en España. Rev Toxicol 18: 19-23.
37. Burdaspal PA y Legarda TM (1998). Datos sobre presencia de ocratoxina A en plasma humano en España. Alimentaria, mayo: 103-9.
38. Creppy EE, Betbeder AM, Charbi A, Counord J, Castegnaro M, Bartsch H, Moncharmont P, Fouillet B, Chambon P, Dirheimer G (1991). En: Castegnaro M, Plestina R, Dieheimer G, Chernozemsky IN, Bartsch H. Ed. Human ochratoxicosis in France. Mycotoxins, endemic nephropathy and urinary tract tumours. IARC Scientific Publications, Lyon: pp. 145-51.
39. Breiholtz-Emanuelsson A, Minervini F, Hult K, Visconti A (1994). Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals suffering from different kidney disorders. Natural Toxins 2: 366-70.
40. Palli D, Miraglia M, Saieva C, Masala G, Cava E, Colatosti M, Corsi AM; Russo A, Brera C (1999). Serum levels of ochratoxin A in healthy adults in Tuscany: correlation with individual characteristics and between repeat measurements. Cancer Epidemiology Biomarkers and Prevention 8: 265-9.
41. Breiholtz-Emanuelsson A, Olsen M, Dahlbäck A, Hult K (1991). Plasma ochratoxin A levels in three Swedish populations surveyed using an ion-pair HPLC technique. Food Addit Contam 8(2): 183-92.
42. Hald B (1991). Ochratoxin A in human blood in European countries. En: Castegnaro M, Plestina R, Dieheimer G, Chernozemsky IN, Bartsch H. Ed. Mycotoxins, endemic nephropathy and urinary tract tumours. IARC scientific publications, Lyon: pp. 159-64.
43. Ruprich J y Ostry V (1993). Study of human exposure to ochratoxin A and assessment of possible sources. Central Eur J Publ Health 1: 46-8.
44. Bauer J y Gareis M (1987). Ochratoxin A in the food chain. Zentral-Veterinarmed-B 34(8): 613-27.
45. Golinsky P, Grabarkiewicz-Szcesna J, Chelkowski J, Hult K, Kostecki M (1991). Possible sources of ochratoxin A in human blood in Poland. En: Castegnaro M, Plestina R, Dieheimer G, Chernozemsky IN, Bartsch H. Ed. Mycotoxins, endemic nephropathy and urinary tract tumours. IARC Scientific Publications, Lyon: pp. 153-8.
46. Krogh P (1976). Epidemiology of mycotoxic porcine nephropathy. Nordisk Veterinaermedicin 28: 452-8.
47. Fuchs R, Radic B, Ceovic S, Sostaric B, Hult K (1991). Human exposure to ochratoxin A. En: Castegnaro M, Plestina R, Dieheimer G, Chernozemsky IN, Bartsch H. Ed. Mycotoxins, endemic nephropathy and urinary tract tumours. IARC Scientific Publications, Lyon: pp. 131-5.
48. Bacha H, Maaroufi K, Achour A, Hamammi M, Ellouz F, Creppy EE (1993). Ochratoxines et ochratoxicoses humaines en Tunisie. En: Creppy EE, Castegnaro M, Dirheimer G. Ed. Human ochratoxicosis and its pathologies, INSERM, John Libbey Eurotext LTD, Paris 231: pp. 111-21.
49. Khalef A, Zidane C, Charef A, Gharbi A, Tadjerouna M, Betbeder AM, Creppy EE (1993). Ochratoxicoses humaines en Algéire. En: Creppy EE, Castegnaro M, Dirheimer G, Ed. Human ochratoxicosis and its pathologies, INSERM, John Libbey Eurotext LTD, Paris 231: pp. 123-7.
50. Filali A, Betbeder AM, Baudrimont I, Benayad A, Soulaymani R, Creppy EE (2002). Ochratoxin A in human plasma in Morocco. A preliminary survey. Human Exp Toxicol 21(5): 241-5.
51. Iavicoli I, Brera C, Carelli G, Caputi R, Marinaccio A, Miraglia M (2002). External and internal dose in subjects occupationally exposed to ochratoxin A. Int Arch Occup Environ Health 75(6): 381-6.
52. Skaug MA (2003). Levels of ochratoxin A and IgG against conidia of Penicillium verrrucosum in blood samples from healthy farm workers. Ann Agric Environ Med 10(1): 73-7.
53. JECFA (1991). Evaluation of certain food additives and contaminants. Thirty-seventh report. WHO Technical Report Series No 806, p. 29-31.
54. JECFA (1995). Evaluation of certain food additives and contaminants. Forty-fourth report. WHO Technical Report Series No 806, p 35-6.
55. Opinion of the Scientific Committee on Food on Ochratoxin A (expressed on 17 September 1998) Consumer Policy and Consumer Health Protection.
56. Comisión Europea. Reglamento (CE) No 472/2002 de la Comisión de 12 marzo de 2002 que modifica el Reglamento (CE) No 466/2001 por el que se fija el contenido máximo de determinados contaminantes en los productos alimenticios. Diario Oficial de las Comunidades Europeas 2002; L 75/18-20.
57. McCann J, Choi E, Yamasaki E, Ames BN (1975). Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc Natl Acad Sci USA 72(12): 5135-9.
58. Kuczuk MH, Benson PM, Heath H, Hayes AW (1978). Evaluation of the mutagenic potential of mycotoxins using Salmonella typhimurium and Saccharomyces cerevisiae. Mutat Res 53: 11-20.
59. Wehner FC, Thiel PG, Van Reusburg SJ, Demasius PC (1978). Mutagenicity to Salmonella typhimurium of some Aspergillus and Penicillium mycotoxins. Mutat Res 58: 193-203.
60. Bendele AM, Neal SB, Oberly TJ, Thompson CZ, Bewsey B, Hill LE, Rexroat MA, Carlton WW, Probst GS (1985). Evaluation of ochratoxin A for mutagenicity in a battery of bacterial and mammalian cell assay. Food Chem Toxicol 23: 911-8.
61. Würgler FE, Friederich U, Schlatter J (1991). Lack of mutagenicity of ochratoxin A and B, citrinin, patulin and cnestine in Salmonella typhimurium TA102. Mutat Res 261: 209-16.
62. Ehrlich V, Darroudi F, Uhl M, Steinkellner H, Gann M, Majer BJ, Eisenbauer M, Knasmüller S (2002). Genotoxic effects of ochratoxin A in human-derived hepatoma (HepG2) cells. Food Chem Toxicol 40: 1085-90.
63. Föllmann W y Lucas S (2003). Effects of the mycotoxin ochratoxin A in bacterial and a mammalian in vitro mutagenicity test system. Arch Toxicol 77(5): 298-304.
64. Henning A, Fink-Gremmels J, Leistner L (1991). Mutagenicity and effects of ochratoxin A on the frecuency of sister chromatid exchange after metabolic activation. En: Castegnaro M, Plestina R, Dirheimer G, Chernozewsky In, Bartsch H. Ed. Mycotoxins, Endemic Nephropathy and urinary track tumors. IARC Scientific Publications, Lyon 115: pp. 255-60.
65. de Groene EM, Hassing IGAM, Blom MJ, Seinen W, Fink-Gremmels J, Horbarch GJ (1996). Development of human cytochrome P450-expressing cell lines: application in mutagenicity testing of ochratoxin A. Cancer Research 56: 299-304.
66. Obrecht-Pflumio S, Chassat T, Dirheimer G, Marzin D (1999). Genotoxicity of ochratoxin A by Salmonella mutagenicity test after bioactivation by mouse kidney microsomes. Mutat Res 446: 95-102.
67. Ueno Y y Kubota K (1976). DNA-attacking ability of carcinogenic mycotoxins in recombination-deficient mutant cells of Bacillus subtilis. Cancer Research 36: 445-51.
68. Kada K, Tsuchikawa K y Sadaie Y (1972). In vitro and host-mediated Rec assay procedures for screening chemical mutagens, and phloxine, mutagenic red dye detected. Mutat Res 16: 165-74.
69. Malaveille C, Vineis P, Estéve J, Ohshima H, Brun G, Hautefeuille A, Gallet P, Ronco G, Terracini B, Bartsch H (1989). Levels of mutagens in the urine of smokers of black and blond tobacco correlate with their risk of bladder cancer. Carcinogenesis 10: 577-86.
70. Sakai M, Abe KI, Okumura H, Kawamura O, Sugiura Y, Horie Y, Ueno Y (1992). Genotoxicity of fungi evaluated by SOS microplate assay. Natural Toxins 1: 27-34.
71. Malaveille C, Brun G, Bartsch H (1994). Structure-activity studies in E. Coli strains on ochratoxin a (OTA) and its analogues implicate a genotoxic free radical and a cytotoxic thiol derivative as reactive metabolites. Mutat Res 307: 141-7.
72. Mori H, Kawai K, Ohbayashi F, Kuniyasu T, Yamazaki M, Hamasaki T, Williams GM (1984). Genotoxicity of a variety of mycotoxins in the hepatocyte primary culture/DNA repair test using rat and mouse hepatocytes. Cancer Research 44: 2918-23.
73. Dörrenhaus A y Föllmann W (1997). Effects of ochratoxin A on DNA repair in cultures of rat hepatocytes and porcine urinary bladder epithelial cells. Arch Toxicol 71: 709-13.
74. Dörrenhaus A, Flieger A, Golka K, Schulze H, Albrecht M, Degen GH, Föllmann W (2000). Induction of unscheduled DNA synthesis in primary human urothelial cells by the mycotoxin ochratoxin A. Toxicol Sci 53: 271-7.
75. 1 in cell lines CHO and AWRF. Folia Biol (Praha) 32: 128-44.
76. Creppy EE, Kane A, Dirheimer G, Lafarge-Frayssinet C, Mousset S, Frayssinet C (1985). Genotoxicity of ochratoxin A in mice: DNA single-strand break evaluation in spleen, liver and kidney. Toxicol Lett 28(1): 29-35.
77. Kane A, Creppy EE, Roth A, Roschenthaler R, Dirheimer G (1986). Distribution of the (3H)-label from low doses of radiactive ochratoxin A ingested by rats, and evidence for DNA single-strand breaks caused in liver and kidneys. Arch Toxicol 58(4): 219-24.
78. Lebrun S y Föllmann W (2002). Detection of ochratoxin A-induced DNA damage in MDCK cells by alcaline single cell gel electrophoresis (comet assay). Arch Toxicol 75: 734-41.
79. Manolova Y, Manolov G, Parvanova L, Petchkova-Bocharova J, Castegnaro M, Chernozemsky I (1990). Induction of characteristic chromosomal aberrations, particulary X-trisomy, in cultured human lymphocytes treated by ochratoxin A, a mycotoxin implicated in Balkan endemic nephropathy. Mutat Res 231: 143-9.
80. Föllmann W, Hillebrand IE, Creppy EE, Bolt HM (1995). Sister chromatid exchange frecuency in cultured isolated porcine urinary bladder epithelial cells (PUBEC) treated with ochratoxin A and alpha. Arch Toxicol 69: 280-6.
81. Degen GH, Gerber MM, Obrecht-Pflumio S, Dirheimer G (1997). Induction of micronuclei with ochratoxin A in ovine seminal vesicle cell cultures. Arch Toxicol 71: 365-71.
82. Dopp E, Müller J, Hahnel C, Schiffmann D (1999). Induction of genotoxic effects and modulation of the intracellular calcium level in syrian hamster embryo (SHE) fibroblast caused by ochratoxin A. Food Chem Toxicol 37: 713-21.
83. Pfohl-Leszkowicz A, Chakor K, Creppy EE, Dirheimer G (1991). DNA adduct formation in mice treated with ochratoxin A. IARC Scientific Publications 115: pp. 245-53.
84. Pfohl-Leszkowicz A, Grosse Y, Kane A, Creppy EE, Dirheimer G (1993a). Differential DNA adduct formation and disappearence in three mouse tissues after treatment with the mycotoxin ochratoxin A. Mutat Res 289: 265-73.
85. Pfohl-Leszkowicz A, Grosse Y, Kane A, Gharbi A, Baudrimont I, Obrecht S, Creppy EE, Dirheimer G (1993b). Is the oxidative pathway implicated in the genotoxicity of ochratoxin A? En: Creppy EE, Castegnaro M, Dirheimer G (eds). Human ochratoxicosis and its pathologies. Colloque INSERM; 231: John Libbey Eurotext, London, pp. 177-87.
86. Obrecht-Pflumio S, Grosse Y, Pfohl-Leszkowicz A, Dirheimer G (1996). Protection by indomethacin and aspirin against genotoxicity of ochratoxin A, particularly in the urinary bladder and kidney. Arch Toxicol 70: 244-8.
87. Grosse Y, Baudrimont I, Castegnaro M, Betbeder AM, Creppy EE, Dirheimer G, y col (1995). Formation of OTA metabolites and DNA-adducts in monkey kidney cells. Chem Biol Interact 95: 175-87.
88. Obrecht-Pflumio S y Dirheimer G (2000). In vitro DNA and dGMP adducts formation caused by ochratoxin A. Chemicobiological interactions 127: 29-44.
89. Gautier J, Richoz J, Welti DH, Markovic J, Gremaud E, Guengerich FP, Turesky RJ (2001). Metabolism of ochratoxin A: absence of formation of genotoxic derivates by human and rat enzymes. Chem Res Toxicol 14(1): 34-45.
90. Gross-Steinmeyer K, Weymann J, Hege H-G, Metzler M (2002). Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin A in cultured rat and human primary hepatocytes. J Agric Food Chem 50: 938-45.
91. El Adlouni C, Pinelli E, Azémar B, Zaoui D, Beaune P, Pfohl-Leszkowicz A (2000). Phenobarbital increases DNA adduct and metabolites formed by ochratoxin A: role of CYP 2C9 and microsomal glutathione-S-transferase. Environmental and Molecular Mutagenesis 35: 123-31.
92. Obrecht-Pflumio S y Dirheimer G (2001). Horseradish peroxidase mediates DNA and deoxyguanosine 3′-monophosphate adduct formation in tha presence of ochratoxin A. Arch Toxicol 75(10): 583-90.